SVA
Sinovac Biotech, Ltd
stock NASDAQ

Yeah, Tower didn’t invent the idea but they have scaled it faster than anyone else (I believe they have doubled their SVAs YTD). Basically they have managed to unbundle alpha from infra. You keep IP and portfolio control while plugging into tech (whatever you may think of Tower’s tech stack but it works for MF), capital and data/market access. Compared with MMHFs where you run inside tight, centralized risk and allocation rules, an SVA shifts you from "renting a PM seat" to actually building your own asset. For proven quant PMs it's a faster, lower operational risk path to ownership with full upside (really good payout ratio as well). So it's no surprise it's gaining traction among top quant talent. Another reason why MMHFs are fighting back with IP ownership offers (as well as slightly looser risk constraints). But again, this applies only to really successful quant PMs.

It's not a standard policy that everyone gets! It's a negotiated term that's reserved for highly successful PMs/SPMs whom platforms are trying to attract. In those cases, MMHFs have become very flexible on IP ownership. Having said that, I'd view complete IP ownership as the exception rather than the rule (pre-existing IP carve-outs are much more common). The PMs I've seen negotiate these arrangements have had exceptional track records.
Given the crowding in stat-arb and the relatively short tenure of many PMs at MMHFs, IP retention has become an important negotiating point. For top PMs with valuable, portable research, it reduces the cost of switching platforms which is why some firms are willing to accommodate it. I think it’s also MMHF’s response to the fact that proven PMs have now credible alternatives which strengthens their negotiating position on issues such as IP ownership. The success of Tower's SVA model shows there's a lot of demand for structures that provide complete IP protection for proven PMs.

Yeah, Tower didn’t invent the idea but they have scaled it faster than anyone else (I believe they have doubled their SVAs YTD). Basically they have managed to unbundle alpha from infra. You keep IP and portfolio control while plugging into tech (whatever you may think of Tower’s tech stack but it works for MF), capital and data/market access. Compared with MMHFs where you run inside tight, centralized risk and allocation rules, an SVA shifts you from "renting a PM seat" to actually building your own asset. For proven quant PMs it's a faster, lower operational risk path to ownership with full upside (really good payout ratio as well). So it's no surprise it's gaining traction among top quant talent. Another reason why MMHFs are fighting back with IP ownership offers (as well as slightly looser risk constraints). But again, this applies only to really successful quant PMs.

It's not a standard policy that everyone gets! It's a negotiated term that's reserved for highly successful PMs/SPMs whom platforms are trying to attract. In those cases, MMHFs have become very flexible on IP ownership. Having said that, I'd view complete IP ownership as the exception rather than the rule (pre-existing IP carve-outs are much more common). The PMs I've seen negotiate these arrangements have had exceptional track records.
Given the crowding in stat-arb and the relatively short tenure of many PMs at MMHFs, IP retention has become an important negotiating point. For top PMs with valuable, portable research, it reduces the cost of switching platforms which is why some firms are willing to accommodate it. I think it’s also MMHF’s response to the fact that proven PMs have now credible alternatives which strengthens their negotiating position on issues such as IP ownership. The success of Tower's SVA model shows there's a lot of demand for structures that provide complete IP protection for proven PMs.